Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Instituto Grifols, S.a.

Clinical trials sponsored by Instituto Grifols, S.a., explained in plain language.

Now part of Grifols, S.A. GRFS NASDAQ

Spanish subsidiary of a global plasma-derived medicines company, focusing on research and development.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Completed 1 Terminated 2

New eye drop aims to soothe dry, irritated eyes

Symptom relief Completed

This study tests an experimental eye drop called GRF312 5% in 100 adults with dry eye disease. The goal is to see if it is safe and helps relieve symptoms. Participants will use the drops at home and attend clinic visits for check-ups.

Phase: PHASE2 • Sponsor: Instituto Grifols, S.A. • Aim: Symptom relief

Last updated Jun 27, 2026 14:00 UTC